Permanent Supportive Housing Overdose Prevention+ Study

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT07214519
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TA Intervention — BEHAVIORAL
    Technical assistance (TA) intervention designed to support PSH agencies in sustainably implementing evidence-based practices to reduce tenant overdose and improve tenant health more broadly.

Study Details

This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.

Key Dates

Start date
Jul 1, 2027
Status verified
May 2026
Primary completion
Sep 30, 2030
Completion
Mar 31, 2031

Study Design

Enrollment
2,940 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Wave 1: Control, Intervention, Sustainment
    Participants at agencies assigned to wave 1 will receive the control condition from months 1-6; intervention for months 6-12; and sustainment from months 12-45.
  • Experimental: Wave 2: Control, Intervention, Sustainment
    Participants at agencies assigned to wave 2 will receive the control condition from months 1-13; intervention for months 13-19; and sustainment from months 19-45.
  • Experimental: Wave 3: Control, Intervention, Sustainment
    Participants at agencies assigned to wave 3 will receive the control condition from months 1-20; intervention for months 20-26; and sustainment from months 26-45.
  • Experimental: Wave 4: Control, Intervention, Sustainment
    Participants at agencies assigned to wave 4 will receive the control condition from months 1-27; intervention for months 27-33; and sustainment from months 33-45.

Primary Outcome Measure

Composite Score of Agency-Level Fidelity to Overdose Prevention Evidence-Based Practices [ Time Frame: Baseline, Month 12 (End of Wave 1), Month 19 (End of Wave 2), Month 26 (End of Wave 3), Month 33 (End of Wave 4) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
NYU Langone Health· New York, NY

Related Studies